FDA’s Bizarre Decisions about Nicotine Pouches Lead to the Wrong Products on Shelves
The FDA’s treatment of NOAT stands out as a case study in inconsistency: a quiet, adult-focused brand approved in Europe yet effectively banned in the US, while flashier and riskier options continue to slip through.











